Annual Current Assets
$446.60 M
+$21.80 M+5.13%
December 31, 2024
Summary
- As of March 10, 2025, AUPH annual total current assets is $446.60 million, with the most recent change of +$21.80 million (+5.13%) on December 31, 2024.
- During the last 3 years, AUPH annual current assets has fallen by -$66.73 million (-13.00%).
- AUPH annual current assets is now -13.00% below its all-time high of $513.32 million, reached on December 31, 2021.
Performance
AUPH Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$446.60 M
+$6.14 M+1.39%
December 31, 2024
Summary
- As of March 10, 2025, AUPH quarterly total current assets is $446.60 million, with the most recent change of +$6.14 million (+1.39%) on December 31, 2024.
- Over the past year, AUPH quarterly current assets has stayed the same.
- AUPH quarterly current assets is now -13.00% below its all-time high of $513.32 million, reached on December 31, 2021.
Performance
AUPH Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
AUPH Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.1% | 0.0% |
3 y3 years | -13.0% | 0.0% |
5 y5 years | +41.7% | 0.0% |
AUPH Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -13.0% | +5.1% | -13.0% | +12.2% |
5 y | 5-year | -13.0% | +41.7% | -13.0% | +60.6% |
alltime | all time | -13.0% | >+9999.0% | -13.0% | >+9999.0% |
Aurinia Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $104.05 M(-15.6%) | $446.60 M(+1.4%) |
Sep 2024 | - | $440.46 M(+7.5%) |
Jun 2024 | - | $409.67 M(+2.9%) |
Mar 2024 | - | $398.22 M(-6.3%) |
Dec 2023 | $123.26 M(+335.2%) | $424.80 M(-0.4%) |
Sep 2023 | - | $426.47 M(+2.5%) |
Jun 2023 | - | $415.91 M(-1.8%) |
Mar 2023 | - | $423.65 M(-4.3%) |
Dec 2022 | $28.32 M(-5.7%) | $442.54 M(-3.7%) |
Sep 2022 | - | $459.70 M(+1.4%) |
Jun 2022 | - | $453.19 M(-5.1%) |
Mar 2022 | - | $477.62 M(-7.0%) |
Dec 2021 | $30.04 M(-32.1%) | $513.32 M(+55.9%) |
Sep 2021 | - | $329.22 M(-5.9%) |
Jun 2021 | - | $349.69 M(-6.1%) |
Mar 2021 | - | $372.25 M(-11.2%) |
Dec 2020 | $44.23 M(+382.7%) | $419.43 M(+1.9%) |
Sep 2020 | - | $411.64 M(+48.1%) |
Jun 2020 | - | $278.02 M(-6.7%) |
Mar 2020 | - | $297.90 M(-5.5%) |
Dec 2019 | $9.16 M(-29.6%) | $315.14 M(+127.3%) |
Sep 2019 | - | $138.64 M(+0.1%) |
Jun 2019 | - | $138.52 M(-8.5%) |
Mar 2019 | - | $151.42 M(+14.0%) |
Dec 2018 | $13.02 M(-10.8%) | $132.85 M(-7.8%) |
Sep 2018 | - | $144.05 M(-6.3%) |
Jun 2018 | - | $153.80 M(-5.1%) |
Mar 2018 | - | $161.98 M(-7.6%) |
Dec 2017 | $14.60 M(-6.3%) | $175.25 M(-5.2%) |
Sep 2017 | - | $184.88 M(-4.0%) |
Jun 2017 | - | $192.49 M(-5.9%) |
Mar 2017 | - | $204.47 M(+393.7%) |
Dec 2016 | $15.58 M(-8.5%) | $41.42 M(+139.1%) |
Sep 2016 | - | $17.32 M(+24.6%) |
Jun 2016 | - | $13.90 M(+25.2%) |
Mar 2016 | - | $11.10 M(-32.9%) |
Dec 2015 | $17.03 M(-9.5%) | $16.53 M(-22.8%) |
Sep 2015 | - | $21.41 M(-18.6%) |
Jun 2015 | - | $26.29 M(-11.1%) |
Mar 2015 | - | $29.57 M(-11.9%) |
Dec 2014 | $18.83 M(-10.6%) | $33.55 M(-9.8%) |
Sep 2014 | - | $37.18 M(-8.5%) |
Jun 2014 | - | $40.61 M(-6.7%) |
Mar 2014 | - | $43.53 M(+1976.7%) |
Dec 2013 | $21.07 M(+467.3%) | $2.10 M(-55.9%) |
Sep 2013 | - | $4.76 M(+599.8%) |
Jun 2013 | - | $679.60 K(+160.0%) |
Mar 2013 | - | $261.40 K(-41.1%) |
Dec 2012 | $3.71 M(-38.1%) | $444.00 K(-87.4%) |
Sep 2012 | - | $3.54 M(-28.0%) |
Jun 2012 | - | $4.91 M(-8.6%) |
Mar 2012 | - | $5.37 M(-35.4%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $6.00 M(+62.1%) | $8.32 M(-29.2%) |
Sep 2011 | - | $11.75 M(+0.1%) |
Jun 2011 | - | $11.74 M(+11.2%) |
Mar 2011 | - | $10.56 M(+60.5%) |
Dec 2010 | $3.70 M(-10.6%) | $6.58 M(-28.1%) |
Sep 2010 | - | $9.15 M(+101.3%) |
Jun 2010 | - | $4.55 M(-18.8%) |
Mar 2010 | - | $5.60 M(+3.6%) |
Dec 2009 | $4.14 M(-15.6%) | $5.40 M(-17.3%) |
Sep 2009 | - | $6.54 M(+0.5%) |
Jun 2009 | - | $6.51 M(-26.8%) |
Mar 2009 | - | $8.88 M(-59.1%) |
Dec 2008 | $4.91 M(-33.1%) | $21.75 M(-20.1%) |
Sep 2008 | - | $27.21 M(-16.2%) |
Jun 2008 | - | $32.48 M(+36.9%) |
Mar 2008 | - | $23.72 M(-32.8%) |
Dec 2007 | $7.34 M(+4.8%) | $35.32 M(-12.5%) |
Sep 2007 | - | $40.38 M(-13.4%) |
Jun 2007 | - | $46.61 M(-6.3%) |
Mar 2007 | - | $49.74 M(+110.5%) |
Dec 2006 | $7.00 M(-6.6%) | $23.63 M(-25.2%) |
Sep 2006 | - | $31.60 M(-15.2%) |
Jun 2006 | - | $37.27 M(-7.9%) |
Mar 2006 | - | $40.48 M(-13.6%) |
Dec 2005 | $7.50 M(-15.6%) | $46.85 M(-11.3%) |
Sep 2005 | - | $52.85 M(+38.7%) |
Jun 2005 | - | $38.10 M(-14.6%) |
Mar 2005 | - | $44.63 M(-14.6%) |
Dec 2004 | $8.89 M(-13.9%) | $52.29 M(-6.1%) |
Sep 2004 | - | $55.68 M(+0.4%) |
Jun 2004 | - | $55.47 M(-8.5%) |
Mar 2004 | - | $60.60 M(-5.5%) |
Dec 2003 | $10.32 M(+50.7%) | $64.11 M(-3.7%) |
Sep 2003 | - | $66.57 M(+15.9%) |
Jun 2003 | - | $57.44 M(+37.5%) |
Mar 2003 | - | $41.78 M(-4.7%) |
Dec 2002 | $6.85 M(+230.2%) | $43.83 M(-8.0%) |
Sep 2002 | - | $47.66 M(-4.3%) |
Jun 2002 | - | $49.80 M(+44.5%) |
Mar 2002 | - | $34.47 M(+20.8%) |
Dec 2001 | $2.07 M(+50.9%) | - |
Aug 2001 | - | $28.53 M(+200.7%) |
May 2001 | - | $9.49 M(-11.8%) |
Feb 2001 | - | $10.76 M(-14.6%) |
Nov 2000 | $1.38 M(+26.5%) | $12.59 M(+14.6%) |
Aug 2000 | - | $10.99 M(-2.0%) |
May 2000 | - | $11.21 M(+207.0%) |
Feb 2000 | - | $3.65 M(+19.5%) |
Nov 1999 | $1.09 M(+11.3%) | $3.06 M(+280.6%) |
Aug 1999 | - | $802.90 K(-52.6%) |
May 1999 | - | $1.70 M(+2.3%) |
Feb 1999 | - | $1.66 M |
Nov 1998 | $976.60 K | - |
FAQ
- What is Aurinia Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual current assets year-on-year change?
- What is Aurinia Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly current assets year-on-year change?
What is Aurinia Pharmaceuticals annual total current assets?
The current annual current assets of AUPH is $446.60 M
What is the all time high annual current assets for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual total current assets is $513.32 M
What is Aurinia Pharmaceuticals annual current assets year-on-year change?
Over the past year, AUPH annual total current assets has changed by +$21.80 M (+5.13%)
What is Aurinia Pharmaceuticals quarterly total current assets?
The current quarterly current assets of AUPH is $446.60 M
What is the all time high quarterly current assets for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly total current assets is $513.32 M
What is Aurinia Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, AUPH quarterly total current assets has changed by $0.00 (0.00%)